Mitsui & Company Venture Partners strikes Irish med-tech deal in Cappella.
Cappella, an Ireland-based developer of medical devices, has raised €10.5m ($14.7m) in its series D round from a consortium including Japanese bank Mitsui’s venturing division.
Mitsui & Company Venture Partners, which separated from Japanese joint venture partner Sumitomo in May, along with venture capital (VC) firms Polytechnos Partners, ACT Venture Capital, Fountain Healthcare Partners and venture debt provider Kreos Capital and Silicon Valley Bank (SVB) made up the consortium.
Phil Cox, head of UK, Europe and Israel at SVB,…
